Your browser doesn't support javascript.
loading
The thalamus and its subnuclei-a gateway to obsessive-compulsive disorder.
Weeland, Cees J; Kasprzak, Selina; de Joode, Niels T; Abe, Yoshinari; Alonso, Pino; Ameis, Stephanie H; Anticevic, Alan; Arnold, Paul D; Balachander, Srinivas; Banaj, Nerisa; Bargallo, Nuria; Batistuzzo, Marcelo C; Benedetti, Francesco; Beucke, Jan C; Bollettini, Irene; Brecke, Vilde; Brem, Silvia; Cappi, Carolina; Cheng, Yuqi; Cho, Kang Ik K; Costa, Daniel L C; Dallaspezia, Sara; Denys, Damiaan; Eng, Goi Khia; Ferreira, Sónia; Feusner, Jamie D; Fontaine, Martine; Fouche, Jean-Paul; Grazioplene, Rachael G; Gruner, Patricia; He, Mengxin; Hirano, Yoshiyuki; Hoexter, Marcelo Q; Huyser, Chaim; Hu, Hao; Jaspers-Fayer, Fern; Kathmann, Norbert; Kaufmann, Christian; Kim, Minah; Koch, Kathrin; Bin Kwak, Yoo; Kwon, Jun Soo; Lazaro, Luisa; Li, Chiang-Shan R; Lochner, Christine; Marsh, Rachel; Martínez-Zalacaín, Ignacio; Mataix-Cols, David; Menchón, Jose M; Minnuzi, Luciano.
Afiliação
  • Weeland CJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam, The Netherlands. c.j.weeland@amsterdamumc.nl.
  • Kasprzak S; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam, The Netherlands.
  • de Joode NT; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam, The Netherlands.
  • Abe Y; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Alonso P; Bellvitge Biomedical Research Insitute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain.
  • Ameis SH; CIBERSAM, Barcelona, Spain.
  • Anticevic A; Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
  • Arnold PD; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
  • Balachander S; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Banaj N; Program in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Bargallo N; Departments of Psychiatry and Neuroscience, Yale University, New Haven, CT, USA.
  • Batistuzzo MC; The Mathison Centre for Mental Health Research & Education, Departments of Psychiatry and Medical Genetics, Calgary, Canada.
  • Benedetti F; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Beucke JC; OCD clinic, Department of Psychiatry, National Institute of Mental Health And Neurosciences (NIMHANS), Bangalore, India.
  • Bollettini I; Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Brecke V; Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Brem S; Image Diagnostic Center, Hospital Clinic, Barcelona, Spain.
  • Cappi C; Departamento de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
  • Cheng Y; Department of Methods and Techniques in Psychology, Pontificial Catholic University of Sao Paulo, Sao Paulo, SP, Brazil.
  • Cho KIK; Vita-Salute San Raffaele University, Milano, Italy.
  • Costa DLC; Psychiatry & Clinical Psychobiology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Dallaspezia S; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Denys D; Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm, Sweden.
  • Eng GK; Department of Medical Psychology, Medical School Hamburg, Hamburg, Germany.
  • Ferreira S; Institute for Systems Medicine and Faculty of Human Medicine, MSH Medical School Hamburg, Hamburg, Germany.
  • Feusner JD; Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • Fontaine M; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
  • Fouche JP; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.
  • Grazioplene RG; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Gruner P; Icahn School of Medicine at Mount Sinai Department of Psychiatry, New York, NY, USA.
  • He M; Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Hirano Y; Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hoexter MQ; Department of Brain and Cognitive Sciences, Seoul National University College of Natural Science, Seoul, Republic of Korea.
  • Huyser C; Obsessive-Compulsive Spectrum Disorders Program, Departamento e Instituto de Psiquiatria, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil.
  • Hu H; IRCCS Ospedale San Raffaele, Milano Italy Psychiatry, Milano, Italy.
  • Jaspers-Fayer F; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Kathmann N; Department of Psychiatry, New York University School of Medicine, New York, NY, USA.
  • Kaufmann C; Clinical Research, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA.
  • Kim M; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • Koch K; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Bin Kwak Y; Clinical Academic Center - Braga, Braga, Portugal.
  • Kwon JS; Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Lazaro L; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA.
  • Li CR; Columbia University Medical College, Columbia University, New York, NY, USA.
  • Lochner C; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Marsh R; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Martínez-Zalacaín I; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Mataix-Cols D; Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Menchón JM; Research Center for Child Mental Development, Chiba University, Chiba, Japan.
  • Minnuzi L; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.
Transl Psychiatry ; 12(1): 70, 2022 02 21.
Article em En | MEDLINE | ID: mdl-35190533
ABSTRACT
Larger thalamic volume has been found in children with obsessive-compulsive disorder (OCD) and children with clinical-level symptoms within the general population. Particular thalamic subregions may drive these differences. The ENIGMA-OCD working group conducted mega- and meta-analyses to study thalamic subregional volume in OCD across the lifespan. Structural T1-weighted brain magnetic resonance imaging (MRI) scans from 2649 OCD patients and 2774 healthy controls across 29 sites (50 datasets) were processed using the FreeSurfer built-in ThalamicNuclei pipeline to extract five thalamic subregions. Volume measures were harmonized for site effects using ComBat before running separate multiple linear regression models for children, adolescents, and adults to estimate volumetric group differences. All analyses were pre-registered ( https//osf.io/73dvy ) and adjusted for age, sex and intracranial volume. Unmedicated pediatric OCD patients (<12 years) had larger lateral (d = 0.46), pulvinar (d = 0.33), ventral (d = 0.35) and whole thalamus (d = 0.40) volumes at unadjusted p-values <0.05. Adolescent patients showed no volumetric differences. Adult OCD patients compared with controls had smaller volumes across all subregions (anterior, lateral, pulvinar, medial, and ventral) and smaller whole thalamic volume (d = -0.15 to -0.07) after multiple comparisons correction, mostly driven by medicated patients and associated with symptom severity. The anterior thalamus was also significantly smaller in patients after adjusting for thalamus size. Our results suggest that OCD-related thalamic volume differences are global and not driven by particular subregions and that the direction of effects are driven by both age and medication status.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tálamo / Transtorno Obsessivo-Compulsivo Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tálamo / Transtorno Obsessivo-Compulsivo Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda